Fortress Biotech, Inc.
NASDAQ:FBIO · NASDAQ Capital Market
-$0.06 today
Vol 0.36M · Avg 0.43M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+74.85%
Period High
$4.38
Period Low
$1.71
Latest
$2.99
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Relmada Therapeutics, Inc.
NASDAQ:RLMD
$482.92M
Immunic, Inc.
NASDAQ:IMUX
$139.10M
Adagene Inc.
NASDAQ:ADAG
$138.17M
Vaxart, Inc.
NASDAQ:VXRT
$135.55M
Gain Therapeutics, Inc.
NASDAQ:GANX
$78.06M
XBiotech Inc.
NASDAQ:XBIT
$71.49M
PMV Pharmaceuticals, Inc.
NASDAQ:PMVP
$59.46M
TScan Therapeutics, Inc.
NASDAQ:TCRX
$55.88M
CervoMed Inc.
CRVO
$37.68M
Nutriband Inc.
NTRB
$37.44M
What is the latest FBIO filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does FBIO have?
Intrinsic Alpha currently shows 20 recent filings for FBIO.
Explore More
Continue the stock analysis
Jump to another research area for this company.